New Flu Treatment May Prevent Pandemic Influenza Outbreaks


Home / New Flu Treatment May Prevent Pandemic Influenza Outbreaks

Could EP67 wipe out fears of the Influenza Virus? Image courtesy of the US CDC

Protection From the Flu: Significance of Influenza Research

According to Dr. Phillips, “The potential to induce immediate immunological protection, even prior to identifying a specific pathogen, is pretty significant.  This has implications for global health and bioterrorism, and even the world food supply.  EP67 works in mammals and birds, so it’s therapeutic potential extends beyond human respiratory disease into veterinary medicine.  Work focused on bioterrorism talks about human pathogens, but protecting the world food supply is an equally important concern.”

Pandemic Flu Fears a Thing of the Past?

The results indicate that EP67 may function as a broad-spectrum emergency therapeutic for diverse respiratory infection.

Decoded Science asked Dr. Joy Phillips, co-author of this study, whether EP67 could be made available to counter SARS, or an influenza pandemic. Her response was an unequivocal, “YES!

Dr. Phillips goes on to tell us, “I absolutely think that EP67 can be used as an emergency treatment against  influenza or SARS.  In fact, I think it has huge potential as an emergency therapeutic following exposure to a myriad of respiratory infections, even prior to their identification.  This could be in a  pathogen exposure, in either a bioterrorism setting, or with the advent of new global pathogens.”

EP67: Protection From the Flu

This research was designed to determine whether EP67, previously used primarily as an immune-enhancer, could provide direct protection in the face of respiratory infection. The results indicate that the stimulation of cells in the airways provides immediate protection, even from an established infection, without compromising the acquired response to infection. These findings may revolutionize flu treatments as well as remove fears of Pandemic Flu outbreaks such as Swine Flu and Bird Flu.


Sanderson, S., et al. Innate Immune Induction and Influenza Protection Elicited by a Response-Selective Agonist of Human C5a. (2012). PLOS One. Accessed July 6, 2012.

Leave a Comment